Clinical Trials Browser

Interventional × Spironolactone × Clear all

NCT07431216 2026-03-30

A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics, and Objective Response of STAR-001 (LP-184) in Combination With Spironolactone in Supratentorial Glioblastoma at First Progression

Phase 1/2 Not yet recruiting

Glioblastoma

NCT03068910 2025-08-05

CRM008

Phase EARLY_PHASE1 Recruiting

Polycystic Ovary Syndrome, Hyperandrogenism

NCT04723862 2025-08-05

CBS010

Phase EARLY_PHASE1 Recruiting

Polycystic Ovary Syndrome, Hyperandrogenism

NCT05933265 2025-03-06

Study of LP-184 in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

Neoplasm Metastasis, Neoplasms, Triple Negative Breast Neoplasms

NCT05394142 2024-04-22

SPIOMET4HEALTH

Phase 2 Recruiting

Polycystic Ovary Syndrome

NCT01422759 2023-10-27

Effect of Spironolactone on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess

Phase NA Unknown

Obesity, Polycystic Ovary Syndrome

NCT04075149 2023-10-27

CBS009

Phase EARLY_PHASE1 Unknown

Polycystic Ovary Syndrome, Hyperandrogenism

NCT06005259 2023-08-22

SPIROTOX

Phase 4 Unknown

Heart Failure, Neoplasms, Cardiotoxicity

NCT03867682 2023-08-04

Venetoclax and Lintuzumab-Ac225 in AML Patients

Phase 1/2 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04190433 2023-05-24

Autophagy Activation for the Alleviation of Cardiomyopathy Symptoms After Anthracycline Treatment, ATACAR Trial

Phase 2 Withdrawn

BreastLymphoidOther hematologic neoplasmSarcoma

Breast Neoplasms, Lymphoma, Sarcoma, Hematologic Neoplasms

NCT01867294 2020-01-09

Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab

Phase 2 Completed

19 enrolled 9 charts

Advanced Malignant Neoplasm

NCT02689843 2019-11-12

AntiPCO

Phase EARLY_PHASE1 Completed

Inflammation, Polycystic Ovary Syndrome

NCT02501213 2019-05-16

Evaluation of the Efficacy of Diuretics for Symptomatic Malignant Ascites Episodes in Advanced Stage of Cancer (DIASC)

Phase 2 Terminated

Neoplasms

NCT02531412 2017-01-04

SPIROCAN

Phase 2/3 Unknown

Neoplasms, Critical Illness, Acute Kidney Injury

NCT01526616 2012-02-06

Spironolactone Plus Metformin in Polycystic Ovary Syndrome

Phase NA Completed

Polycystic Ovary Syndrome, Hyperandrogenism, Metabolic Syndrome

NCT00842140 2010-07-22

Safety of Hormonal Contraceptives Therapies in Polycystic Ovary Syndrome (PCOS) Women

Phase NA Completed

Cardiovascular Diseases, Polycystic Ovary Syndrome

NCT00004311 2005-06-24

Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome

Phase 2 Completed

Acanthosis Nigricans, Endocrine System Diseases, Polycystic Ovary Syndrome, Skin Diseases, Rare Diseases